 | • レポートコード：QY20ST-09824 • 出版社/出版日：QYResearch / 2020年9月15日 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、143ページ • 納品方法：Eメール（受注後2~3営業日） • 産業分類：医薬品、医療 |
| Single User | ￥560,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥840,000 (USD6,000) | ▷ お問い合わせ |
| Enterprise License | ￥1,120,000 (USD8,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、世界の大腸がん治療薬市場について種類別（血管内皮成長因子（VEGF）阻害剤、上皮成長因子受容体（EGFR）阻害剤、プログラム細胞死タンパク質1 / PD1リガンド1（PD1 / PDL1）阻害剤、BRAF・MEK阻害剤、チロシンキナーゼ（TKI）阻害剤、免疫調節剤）、用途別（Radiotherapy、 Chemotherapy）、地域別（北米、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2015年～2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。 ・大腸がん治療薬市場の概要 ・世界の主要地域別大腸がん治療薬市場規模2015-2026 ・主要プレイヤーの競争状況・市場シェア ・世界の大腸がん治療薬市場規模2015-2026：種類別（血管内皮成長因子（VEGF）阻害剤、上皮成長因子受容体（EGFR）阻害剤、プログラム細胞死タンパク質1 / PD1リガンド1（PD1 / PDL1）阻害剤、BRAF・MEK阻害剤、チロシンキナーゼ（TKI）阻害剤、免疫調節剤） ・世界の大腸がん治療薬市場規模2015-2026：用途別（Radiotherapy、 Chemotherapy） ・大腸がん治療薬の北米市場規模2015-2020 ・大腸がん治療薬のヨーロッパ市場規模2015-2020 ・大腸がん治療薬の中国市場規模2015-2020 ・大腸がん治療薬の日本市場規模2015-2020 ・大腸がん治療薬の東南アジア市場規模2015-2020 ・大腸がん治療薬のインド市場規模2015-2020 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 ・大腸がん治療薬の製造コスト分析 ・販売チャネル、流通業者、顧客 ・大腸がん治療薬の市場動向・機会・課題 ・調査の結論 |
A recently published report by QY Research titled Global Colorectal Cancer Drugs Sales Market Report 2020 is designed in a way that helps the readers to acquire a complete knowledge about the overall market scenario and it’s most lucrative sectors. The research report also statistically provides accurate data in a statistical manner. It examines the historic accomplishments and recent opportunities present in the global Colorectal Cancer Drugs market. QY Research report focuses on the consumption, geography, by type, by application, and the competitive landscape. The 4000 version of the report mainly splits the data for each region to analyze the leading companies, applications, and product types.
QY Research aims to provide a complete knowledgeable report so that the readers will benefit from it. The report is properly examined and compiled by industry experts and will shed light on the key information that requires from the clients.
Report Overview:
There are few available adjuvant/neoadjuvant medicines for treatment of high-risk resectable colorectal cancer. Lack of pipeline agents in this setting presents a good opportunity for development of effective treatments that can improve cure rates for resected patients.
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Colorectal Cancer Drugs market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Colorectal Cancer Drugs industry.
Based on our recent survey, we have several different scenarios about the Colorectal Cancer Drugs YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ 8201.8 million in 2019. The market size of Colorectal Cancer Drugs will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
QY Research report provides an overview and scope of the global Colorectal Cancer Drugs market, stating its drivers, trends, opportunities, and restraints. The report also comprises all key details of the global Colorectal Cancer Drugs market such as market strategies, sales volumes, and consumption. The report also covers the names of all distribution channels such as manufacturers, suppliers, wholesalers, distributors, consumers, and dealers.
QY Research also presents the statistical data in the form of infographics, tables, and charts to predict the trends and developments of the global Colorectal Cancer Drugs market over the forecast period. The research analysts have also used a framework such as key industry experts interview, research papers, refer journals, survey reports, and face-to-face interviews with expert professionals to know the detailed outlook of the global Colorectal Cancer Drugs market. The report also includes nautical information, where it shows Colorectal Cancer Drugs market product volume, utilization value, and production processes.
The research report also consists of a competitive landscape that describes the top players that are functioning in the global Colorectal Cancer Drugs market. This report also describes the key developments and trends, mergers and acquisitions strategies, and new product innovation that will show an enormous benefit to the companies that are competing in the global Colorectal Cancer Drugs market.
Geographical Analysis:
Based on region, the global Colorectal Cancer Drugs market is segmented into North America, Europe, China, Japan, Southeast Asia India and Other regions (Middle East & Africa, Central & South America). Research analysts have studied government initiatives, changing the political environment, and social scenarios that are likely to contribute to the growth of the regional markets.
Key Players:
The major players that are operating in the global Colorectal Cancer Drugs market are
AB Science
Amgen
Array BioPharma
Bayer
Boehringer Ingelheim
Bristol-Myers Squibb
Elli Lilly
Roch
Hutchison MediPharma
Merck & Co., Inc.
Mologen
Regeneron
Sanofi
Sumitomo Dainippon
Taiho Pharmaceutical
Vaccinogen
Segment by Type
Vascular Endothelial Growth Factor (VEGF) Inhibitors
Epidermal Growth Factor Receptor (EGFR) Inhibitors
Programmed Cell Death Protein 1/PD1 Ligand 1 (PD1/PDL1) Inhibitors
BRAF or MEK Inhibitors
Tyrosine Kinase (TKI) Inhibitors
Immunomodulators
Segment by Application
Radiotherapy
Chemotherapy
Competitive Landscape:
Factors such as cost analysis, marketing strategy, factor analysis, distributors, sourcing strategy, and industrial chain are all the parts of the global Colorectal Cancer Drugs market. The report also includes the analysis of the return on investment (ROI) feasibility with the estimated SWOT analysis.
The report covers the following objectives:
• Proliferation and maturation of trade in the global Colorectal Cancer Drugs market.
• The market share of the global Colorectal Cancer Drugs market, supply and demand ratio, growth revenue, supply chain analysis, and business overview.
• Current and future market trends that are influencing the growth opportunities and growth rate of the global Colorectal Cancer Drugs market.
• Feasibility study, new market insights, company profiles, investment return, revenue (value), and consumption (volume) of the global Colorectal Cancer Drugs market.
1 Colorectal Cancer Drugs Market Overview
1.1 Colorectal Cancer Drugs Product Scope
1.2 Colorectal Cancer Drugs Segment by Type
1.2.1 Global Colorectal Cancer Drugs Sales by Type (2020-2026)
1.2.2 Vascular Endothelial Growth Factor (VEGF) Inhibitors
1.2.3 Epidermal Growth Factor Receptor (EGFR) Inhibitors
1.2.4 Programmed Cell Death Protein 1/PD1 Ligand 1 (PD1/PDL1) Inhibitors
1.2.5 BRAF or MEK Inhibitors
1.2.6 Tyrosine Kinase (TKI) Inhibitors
1.2.7 Immunomodulators
1.3 Colorectal Cancer Drugs Segment by Application
1.3.1 Global Colorectal Cancer Drugs Sales Comparison by Application (2020-2026)
1.3.2 Radiotherapy
1.3.3 Chemotherapy
1.4 Colorectal Cancer Drugs Market Estimates and Forecasts (2015-2026)
1.4.1 Global Colorectal Cancer Drugs Sales Growth Rate (2015-2026)
1.4.2 Global Colorectal Cancer Drugs Revenue and Growth Rate (2015-2026)
1.4.3 Global Colorectal Cancer Drugs Price Trends (2015-2026)
1.5 Coronavirus Disease 2019 (Covid-19): Colorectal Cancer Drugs Industry Impact
1.5.1 How the Covid-19 is Affecting the Colorectal Cancer Drugs Industry
1.5.1.1 Colorectal Cancer Drugs Business Impact Assessment – Covid-19
1.5.1.2 Supply Chain Challenges
1.5.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.5.2 Market Trends and Colorectal Cancer Drugs Potential Opportunities in the COVID-19 Landscape
1.5.3 Measures / Proposal against Covid-19
1.5.3.1 Government Measures to Combat Covid-19 Impact
1.5.3.2 Proposal for Colorectal Cancer Drugs Players to Combat Covid-19 Impact
2 Colorectal Cancer Drugs Estimate and Forecast by Region
2.1 Global Colorectal Cancer Drugs Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Colorectal Cancer Drugs Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Colorectal Cancer Drugs Sales Market Share by Region (2015-2020)
2.2.2 Global Colorectal Cancer Drugs Revenue Market Share by Region (2015-2020)
2.3 Global Colorectal Cancer Drugs Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Colorectal Cancer Drugs Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Colorectal Cancer Drugs Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Colorectal Cancer Drugs Estimates and Projections (2015-2026)
2.4.2 Europe Colorectal Cancer Drugs Estimates and Projections (2015-2026)
2.4.3 China Colorectal Cancer Drugs Estimates and Projections (2015-2026)
2.4.4 Japan Colorectal Cancer Drugs Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Colorectal Cancer Drugs Estimates and Projections (2015-2026)
2.4.6 India Colorectal Cancer Drugs Estimates and Projections (2015-2026)
3 Global Colorectal Cancer Drugs Competition Landscape by Players
3.1 Global Top Colorectal Cancer Drugs Players by Sales (2015-2020)
3.2 Global Top Colorectal Cancer Drugs Players by Revenue (2015-2020)
3.3 Global Colorectal Cancer Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Colorectal Cancer Drugs as of 2019)
3.4 Global Colorectal Cancer Drugs Average Price by Company (2015-2020)
3.5 Manufacturers Colorectal Cancer Drugs Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Colorectal Cancer Drugs Players (Opinion Leaders)
4 Global Colorectal Cancer Drugs Market Size by Type
4.1 Global Colorectal Cancer Drugs Historic Market Review by Type (2015-2020)
4.1.1 Global Colorectal Cancer Drugs Sales Market Share by Type (2015-2020)
4.1.2 Global Colorectal Cancer Drugs Revenue Market Share by Type (2015-2020)
4.1.3 Global Colorectal Cancer Drugs Price by Type (2014-2020)
4.2 Global Colorectal Cancer Drugs Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Colorectal Cancer Drugs Sales Forecast by Type (2021-2026)
4.2.2 Global Colorectal Cancer Drugs Revenue Forecast by Type (2021-2026)
4.2.3 Global Colorectal Cancer Drugs Price Forecast by Type (2021-2026)
5 Global Colorectal Cancer Drugs Market Size by Application
5.1 Global Colorectal Cancer Drugs Historic Market Review by Application (2015-2020)
5.1.1 Global Colorectal Cancer Drugs Sales Market Share by Application (2015-2020)
5.1.2 Global Colorectal Cancer Drugs Revenue Market Share by Application (2015-2020)
5.1.3 Global Colorectal Cancer Drugs Price by Application (2015-2020)
5.2 Global Colorectal Cancer Drugs Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Colorectal Cancer Drugs Sales Forecast by Application (2021-2026)
5.2.2 Global Colorectal Cancer Drugs Revenue Forecast by Application (2021-2026)
5.2.3 Global Colorectal Cancer Drugs Price Forecast by Application (2021-2026)
3 North America Colorectal Cancer Drugs Market Facts & Figures
3.2 North America Colorectal Cancer Drugs Sales Market Share by Company (2015-2020)
3.3 North America Colorectal Cancer Drugs Sales Market Share by Type (2015-2020)
3.4 North America Colorectal Cancer Drugs Sales Market Share by Application (2015-2020)
4 Europe Colorectal Cancer Drugs Market Facts & Figures
4.2 Europe Colorectal Cancer Drugs Sales Market Share by Company (2015-2020)
4.3 Europe Colorectal Cancer Drugs Sales Market Share by Type (2015-2020)
4.4 Europe Colorectal Cancer Drugs Sales Market Share by Application (2015-2020)
5 China Colorectal Cancer Drugs Market Facts & Figures
5.2 China Colorectal Cancer Drugs Sales Market Share by Company (2015-2020)
5.3 China Colorectal Cancer Drugs Sales Market Share by Type (2015-2020)
5.4 China Colorectal Cancer Drugs Sales Market Share by Application (2015-2020)
6 Japan Colorectal Cancer Drugs Market Facts & Figures
6.2 Japan Colorectal Cancer Drugs Sales Market Share by Company (2015-2020)
6.3 Japan Colorectal Cancer Drugs Sales Market Share by Type (2015-2020)
6.4 Japan Colorectal Cancer Drugs Sales Market Share by Application (2015-2020)
7 Southeast Asia Colorectal Cancer Drugs Market Facts & Figures
7.2 Southeast Asia Colorectal Cancer Drugs Sales Market Share by Company (2015-2020)
7.3 Southeast Asia Colorectal Cancer Drugs Sales Market Share by Type (2015-2020)
7.4 Southeast Asia Colorectal Cancer Drugs Sales Market Share by Application (2015-2020)
8 India Colorectal Cancer Drugs Market Facts & Figures
8.2 India Colorectal Cancer Drugs Sales Market Share by Company (2015-2020)
8.3 India Colorectal Cancer Drugs Sales Market Share by Type (2015-2020)
8.4 India Colorectal Cancer Drugs Sales Market Share by Application (2015-2020)
12 Company Profiles and Key Figures in Colorectal Cancer Drugs Business
12.1 AB Science
12.1.1 AB Science Colorectal Cancer Drugs Corporation Information
12.1.2 AB Science Colorectal Cancer Drugs Business Overview and Total Revenue
12.1.3 AB Science Colorectal Cancer Drugs Sales, Revenue and Gross Margin (2015-2020)
12.1.4 AB Science Colorectal Cancer Drugs Products Offered
12.1.5 AB Science Recent Development
12.2 Amgen
12.2.1 Amgen Colorectal Cancer Drugs Corporation Information
12.2.2 Amgen Colorectal Cancer Drugs Business Overview and Total Revenue
12.2.3 Amgen Colorectal Cancer Drugs Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Amgen Colorectal Cancer Drugs Products Offered
12.2.5 Amgen Recent Development
12.3 Array BioPharma
12.3.1 Array BioPharma Colorectal Cancer Drugs Corporation Information
12.3.2 Array BioPharma Colorectal Cancer Drugs Business Overview and Total Revenue
12.3.3 Array BioPharma Colorectal Cancer Drugs Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Array BioPharma Colorectal Cancer Drugs Products Offered
12.3.5 Array BioPharma Recent Development
12.4 Bayer
12.4.1 Bayer Colorectal Cancer Drugs Corporation Information
12.4.2 Bayer Colorectal Cancer Drugs Business Overview and Total Revenue
12.4.3 Bayer Colorectal Cancer Drugs Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Bayer Colorectal Cancer Drugs Products Offered
12.4.5 Bayer Recent Development
12.5 Boehringer Ingelheim
12.5.1 Boehringer Ingelheim Colorectal Cancer Drugs Corporation Information
12.5.2 Boehringer Ingelheim Colorectal Cancer Drugs Business Overview and Total Revenue
12.5.3 Boehringer Ingelheim Colorectal Cancer Drugs Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Boehringer Ingelheim Colorectal Cancer Drugs Products Offered
12.5.5 Boehringer Ingelheim Recent Development
12.6 Bristol-Myers Squibb
12.6.1 Bristol-Myers Squibb Colorectal Cancer Drugs Corporation Information
12.6.2 Bristol-Myers Squibb Colorectal Cancer Drugs Business Overview and Total Revenue
12.6.3 Bristol-Myers Squibb Colorectal Cancer Drugs Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Bristol-Myers Squibb Colorectal Cancer Drugs Products Offered
12.6.5 Bristol-Myers Squibb Recent Development
12.7 Elli Lilly
12.7.1 Elli Lilly Colorectal Cancer Drugs Corporation Information
12.7.2 Elli Lilly Colorectal Cancer Drugs Business Overview and Total Revenue
12.7.3 Elli Lilly Colorectal Cancer Drugs Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Elli Lilly Colorectal Cancer Drugs Products Offered
12.7.5 Elli Lilly Recent Development
12.8 Roch
12.8.1 Roch Colorectal Cancer Drugs Corporation Information
12.8.2 Roch Colorectal Cancer Drugs Business Overview and Total Revenue
12.8.3 Roch Colorectal Cancer Drugs Sales, Revenue and Gross Margin (2015-2020)
12.8.4 Roch Colorectal Cancer Drugs Products Offered
12.8.5 Roch Recent Development
12.9 Hutchison MediPharma
12.9.1 Hutchison MediPharma Colorectal Cancer Drugs Corporation Information
12.9.2 Hutchison MediPharma Colorectal Cancer Drugs Business Overview and Total Revenue
12.9.3 Hutchison MediPharma Colorectal Cancer Drugs Sales, Revenue and Gross Margin (2015-2020)
12.9.4 Hutchison MediPharma Colorectal Cancer Drugs Products Offered
12.9.5 Hutchison MediPharma Recent Development
12.10 Merck & Co., Inc.
12.10.1 Merck & Co., Inc. Colorectal Cancer Drugs Corporation Information
12.10.2 Merck & Co., Inc. Colorectal Cancer Drugs Business Overview and Total Revenue
12.10.3 Merck & Co., Inc. Colorectal Cancer Drugs Sales, Revenue and Gross Margin (2015-2020)
12.10.4 Merck & Co., Inc. Colorectal Cancer Drugs Products Offered
12.10.5 Merck & Co., Inc. Recent Development
12.11 Mologen
12.11.1 Mologen Colorectal Cancer Drugs Corporation Information
12.11.2 Mologen Colorectal Cancer Drugs Business Overview and Total Revenue
12.11.3 Mologen Colorectal Cancer Drugs Sales, Revenue and Gross Margin (2015-2020)
12.11.4 Mologen Colorectal Cancer Drugs Products Offered
12.11.5 Mologen Recent Development
12.12 Regeneron
12.12.1 Regeneron Colorectal Cancer Drugs Corporation Information
12.12.2 Regeneron Colorectal Cancer Drugs Business Overview and Total Revenue
12.12.3 Regeneron Colorectal Cancer Drugs Sales, Revenue and Gross Margin (2015-2020)
12.12.4 Regeneron Colorectal Cancer Drugs Products Offered
12.12.5 Regeneron Recent Development
12.13 Sanofi
12.13.1 Sanofi Colorectal Cancer Drugs Corporation Information
12.13.2 Sanofi Colorectal Cancer Drugs Business Overview and Total Revenue
12.13.3 Sanofi Colorectal Cancer Drugs Sales, Revenue and Gross Margin (2015-2020)
12.13.4 Sanofi Colorectal Cancer Drugs Products Offered
12.13.5 Sanofi Recent Development
12.14 Sumitomo Dainippon
12.14.1 Sumitomo Dainippon Colorectal Cancer Drugs Corporation Information
12.14.2 Sumitomo Dainippon Colorectal Cancer Drugs Business Overview and Total Revenue
12.14.3 Sumitomo Dainippon Colorectal Cancer Drugs Sales, Revenue and Gross Margin (2015-2020)
12.14.4 Sumitomo Dainippon Colorectal Cancer Drugs Products Offered
12.14.5 Sumitomo Dainippon Recent Development
12.15 Taiho Pharmaceutical
12.15.1 Taiho Pharmaceutical Colorectal Cancer Drugs Corporation Information
12.15.2 Taiho Pharmaceutical Colorectal Cancer Drugs Business Overview and Total Revenue
12.15.3 Taiho Pharmaceutical Colorectal Cancer Drugs Sales, Revenue and Gross Margin (2015-2020)
12.15.4 Taiho Pharmaceutical Colorectal Cancer Drugs Products Offered
12.15.5 Taiho Pharmaceutical Recent Development
12.16 Vaccinogen
12.16.1 Vaccinogen Colorectal Cancer Drugs Corporation Information
12.16.2 Vaccinogen Colorectal Cancer Drugs Business Overview and Total Revenue
12.16.3 Vaccinogen Colorectal Cancer Drugs Sales, Revenue and Gross Margin (2015-2020)
12.16.4 Vaccinogen Colorectal Cancer Drugs Products Offered
12.16.5 Vaccinogen Recent Development
13 Colorectal Cancer Drugs Manufacturing Cost Analysis
13.1 Colorectal Cancer Drugs Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Colorectal Cancer Drugs
13.4 Colorectal Cancer Drugs Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Colorectal Cancer Drugs Distributors List
14.3 Colorectal Cancer Drugs Customers
15 Market Dynamics
15.1 Market Trends
15.2 Opportunities and Drivers
15.3 Challenges
15.4 Porter’s Five Forces Analysis
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Colorectal Cancer Drugs Sales (MT) Growth Rate by Type (2020-2026)
Table 2. Global Colorectal Cancer Drugs Sales (MT) Comparison by Application (2020-2026)
Table 3. COVID-19 Impact Global Market: (Four Colorectal Cancer Drugs Market Size Forecast Scenarios)
Table 4. Opportunities and Trends for Colorectal Cancer Drugs Players in the COVID-19 Landscape
Table 5. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 6. Key Regions/Countries Measures against Covid-19 Impact
Table 7. Proposal for Colorectal Cancer Drugs Players to Combat Covid-19 Impact
Table 8. Global Market Colorectal Cancer Drugs Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 9. Global Colorectal Cancer Drugs Sales (MT) by Region (2015-2020)
Table 10. Global Colorectal Cancer Drugs Sales Market Share by Region (2015-2020)
Table 11. Global Colorectal Cancer Drugs Revenue (US$ Million) Market Share by Region (2015-2020))
Table 12. Global Colorectal Cancer Drugs Revenue Share by Region (2015-2020)
Table 13. Global Colorectal Cancer Drugs Sales (MT) Forecast by Region (2021-2026)
Table 14. Global Colorectal Cancer Drugs Sales Market Share Forecast by Region (2021-2026)
Table 15. Global Colorectal Cancer Drugs Revenue (US$ Million) Forecast by Region (2021-2026)
Table 16. Global Colorectal Cancer Drugs Revenue Share Forecast by Region (2021-2026)
Table 17. Global Colorectal Cancer Drugs (MT) of Key Companies (2015-2020)
Table 18. Global Colorectal Cancer Drugs Sales Share by Company (2015-2020)
Table 19. Global Colorectal Cancer Drugs Revenue (US$ Million) by Company (2015-2020)
Table 20. Global Colorectal Cancer Drugs Revenue Share by Company (2015-2020)
Table 21. Global Colorectal Cancer Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Colorectal Cancer Drugs as of 2019)
Table 22. Global Colorectal Cancer Drugs Average Price (USD/Kg) of Key Company (2015-2020)
Table 23. Manufacturers Colorectal Cancer Drugs Manufacturing Sites and Area Served
Table 24. Manufacturers Colorectal Cancer Drugs Product Type
Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 26. Main Points Interviewed from Key Colorectal Cancer Drugs Players
Table 27. Global Colorectal Cancer Drugs Sales (MT) by Type (2015-2020)
Table 28. Global Colorectal Cancer Drugs Sales Share by Type (2015-2020)
Table 29. Global Colorectal Cancer Drugs Revenue (US$ Million) Market Share by Type (2015-2020)
Table 30. Global Colorectal Cancer Drugs Price (MT) by Type (2015-2020)
Table 31. Global Colorectal Cancer Drugs Sales Share by Type (2021-2026)
Table 32. Global Colorectal Cancer Drugs Revenue (US$ Million) Market Share by Type (2021-2026)
Table 33. Global Colorectal Cancer Drugs Revenue Share by Type (2021-2026)
Table 34. Global Colorectal Cancer Drugs Price (MT) by Type (2021-2026)
Table 35. Global Colorectal Cancer Drugs Sales (MT) by Application (2015-2020)
Table 36. Global Colorectal Cancer Drugs Sales Share by Application (2015-2020)
Table 37. Global Colorectal Cancer Drugs Revenue (US$ Million) Market Share by Application (2015-2020)
Table 38. Global Colorectal Cancer Drugs Price (MT) by Application (2015-2020)
Table 39. Global Colorectal Cancer Drugs Sales (MT) by Application (2021-2026)
Table 40. Global Colorectal Cancer Drugs Sales Share by Application (2021-2026)
Table 41. Global Colorectal Cancer Drugs Revenue (US$ Million) Market Share by Application (2021-2026)
Table 42. Global Colorectal Cancer Drugs Revenue Share by Application (2021-2026)
Table 43. Global Colorectal Cancer Drugs Price (MT) by Application (2021-2026)
Table 44. United States Colorectal Cancer Drugs Sales (MT) by Company (2015-2020)
Table 45. United States Colorectal Cancer Drugs Sales Market Share by Company (2015-2020)
Table 46. United States Colorectal Cancer Drugs Sales (MT) by Type (2015-2020)
Table 47. United States Colorectal Cancer Drugs Sales Market Share by Type (2015-2020)
Table 48. United States Colorectal Cancer Drugs Sales (MT) by Application (2015-2020)
Table 49. United States Colorectal Cancer Drugs Sales Market Share by Application (2015-2020)
Table 50. Europe Colorectal Cancer Drugs Sales (MT) by Company (2015-2020)
Table 51. Europe Colorectal Cancer Drugs Sales Market Share by Company (2015-2020)
Table 52. Europe Colorectal Cancer Drugs Sales (MT) by Type (2015-2020)
Table 53. Europe Colorectal Cancer Drugs Sales Market Share by Type (2015-2020)
Table 54. Europe Colorectal Cancer Drugs Sales (MT) by Application (2015-2020)
Table 55. Europe Colorectal Cancer Drugs Sales Market Share by Type (2015-2020)
Table 56. China Colorectal Cancer Drugs Sales (MT) by Company (2015-2020)
Table 57. China Colorectal Cancer Drugs Sales Market Share by Company (2015-2020)
Table 58. China Colorectal Cancer Drugs Sales (MT) by Type (2015-2020)
Table 59. China Colorectal Cancer Drugs Sales Market Share by Type (2015-2020)
Table 60. China Colorectal Cancer Drugs Sales (MT) by Application (2015-2020)
Table 61. China Colorectal Cancer Drugs Sales Market Share by Application (2015-2020)
Table 62. Japan Colorectal Cancer Drugs Sales (MT) by Company (2015-2020)
Table 63. Japan Colorectal Cancer Drugs Sales Market Share by Company (2015-2020)
Table 64. Japan Colorectal Cancer Drugs Sales (MT) by Type (2015-2020)
Table 65. Japan Colorectal Cancer Drugs Sales Market Share by Type (2015-2020)
Table 66. Japan Colorectal Cancer Drugs Sales (MT) by Application (2015-2020)
Table 67. Japan Colorectal Cancer Drugs Sales Market Share by Application (2015-2020)
Table 68. Southeast Asia Colorectal Cancer Drugs Sales (MT) by Company (2015-2020)
Table 69. Southeast Asia Colorectal Cancer Drugs Sales Market Share by Company (2015-2020)
Table 70. Southeast Asia Colorectal Cancer Drugs Sales (MT) by Type (2015-2020)
Table 71. Southeast Asia Colorectal Cancer Drugs Sales Market Share by Type (2015-2020)
Table 72. Southeast Asia Colorectal Cancer Drugs Sales (MT) by Type (2015-2020)
Table 73. Southeast Asia Colorectal Cancer Drugs Sales Market Share by Application (2015-2020)
Table 74. India Colorectal Cancer Drugs Sales (MT) by Company (2015-2020)
Table 75. India Colorectal Cancer Drugs Sales Market Share by Company (2015-2020)
Table 76. India Colorectal Cancer Drugs Sales (MT) by Type (2015-2020)
Table 77. India Colorectal Cancer Drugs Sales Market Share by Type (2015-2020)
Table 78. India Colorectal Cancer Drugs Sales (MT) by Application (2015-2020)
Table 79. India Colorectal Cancer Drugs Sales Market Share by Application (2015-2020)
Table 80. AB Science Corporation Information
Table 81. AB Science Description and Business Overview
Table 82. AB Science Colorectal Cancer Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 83. AB Science Colorectal Cancer Drugs Product
Table 84. AB Science Recent Development
Table 85. Amgen Corporation Information
Table 86. Amgen Description and Business Overview
Table 87. Amgen Colorectal Cancer Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 88. Amgen Colorectal Cancer Drugs Product
Table 89. Amgen Recent Development
Table 90. Array BioPharma Corporation Information
Table 91. Array BioPharma Description and Business Overview
Table 92. Array BioPharma Colorectal Cancer Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 93. Array BioPharma Colorectal Cancer Drugs Product
Table 94. Array BioPharma Recent Development
Table 95. Bayer Corporation Information
Table 96. Bayer Description and Business Overview
Table 97. Bayer Colorectal Cancer Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 98. Bayer Colorectal Cancer Drugs Product
Table 99. Bayer Recent Development
Table 100. Boehringer Ingelheim Corporation Information
Table 101. Boehringer Ingelheim Description and Business Overview
Table 102. Boehringer Ingelheim Colorectal Cancer Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 103. Boehringer Ingelheim Colorectal Cancer Drugs Product
Table 104. Boehringer Ingelheim Recent Development
Table 105. Bristol-Myers Squibb Corporation Information
Table 106. Bristol-Myers Squibb Description and Business Overview
Table 107. Bristol-Myers Squibb Colorectal Cancer Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 108. Bristol-Myers Squibb Colorectal Cancer Drugs Product
Table 109. Bristol-Myers Squibb Recent Development
Table 110. Elli Lilly Corporation Information
Table 111. Elli Lilly Description and Business Overview
Table 112. Elli Lilly Colorectal Cancer Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 113. Elli Lilly Colorectal Cancer Drugs Product
Table 114. Elli Lilly Recent Development
Table 115. Roch Corporation Information
Table 116. Roch Colorectal Cancer Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 117. Roch Description and Business Overview
Table 118. Roch Colorectal Cancer Drugs Product
Table 119. Roch Recent Development
Table 120. Hutchison MediPharma Corporation Information
Table 121. Hutchison MediPharma Colorectal Cancer Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 122. Hutchison MediPharma Description and Business Overview
Table 123. Hutchison MediPharma Colorectal Cancer Drugs Product
Table 124. Hutchison MediPharma Recent Development
Table 125. Merck & Co., Inc. Corporation Information
Table 126. Merck & Co., Inc. Description and Business Overview
Table 127. Merck & Co., Inc. Colorectal Cancer Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 128. Merck & Co., Inc. Colorectal Cancer Drugs Product
Table 129. Merck & Co., Inc. Recent Development
Table 130. Mologen Corporation Information
Table 131. Mologen Description and Business Overview
Table 132. Mologen Colorectal Cancer Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 133. Mologen Colorectal Cancer Drugs Product
Table 134. Mologen Recent Development
Table 135. Regeneron Corporation Information
Table 136. Regeneron Description and Business Overview
Table 137. Regeneron Colorectal Cancer Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 138. Regeneron Colorectal Cancer Drugs Product
Table 139. Regeneron Recent Development
Table 140. Sanofi Corporation Information
Table 141. Sanofi Description and Business Overview
Table 142. Sanofi Colorectal Cancer Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 143. Sanofi Colorectal Cancer Drugs Product
Table 144. Sanofi Recent Development
Table 145. Sumitomo Dainippon Corporation Information
Table 146. Sumitomo Dainippon Description and Business Overview
Table 147. Sumitomo Dainippon Colorectal Cancer Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 148. Sumitomo Dainippon Colorectal Cancer Drugs Product
Table 149. Sumitomo Dainippon Recent Development
Table 150. Taiho Pharmaceutical Corporation Information
Table 151. Taiho Pharmaceutical Description and Business Overview
Table 152. Taiho Pharmaceutical Colorectal Cancer Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 153. Taiho Pharmaceutical Colorectal Cancer Drugs Product
Table 154. Taiho Pharmaceutical Recent Development
Table . Vaccinogen Corporation Information
Table . Vaccinogen Description and Business Overview
Table . Vaccinogen Colorectal Cancer Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table . Vaccinogen Colorectal Cancer Drugs Product
Table . Vaccinogen Recent Development
Table 160. Production Base and Market Concentration Rate of Raw Material
Table 161. Key Suppliers of Raw Materials
Table 162. Colorectal Cancer Drugs Distributors List
Table 163. Colorectal Cancer Drugs Customers List
Table 164. Market Key Trends
Table 165. Key Opportunities and Drivers: Impact Analysis (2020-2026)
Table 166. Key Challenges
Table 167. Research Programs/Design for This Report
Table 168. Key Data Information from Secondary Sources
Table 169. Key Data Information from Primary Sources
List of Figures
Figure 1. Colorectal Cancer Drugs Product Picture
Figure 2. Global Colorectal Cancer Drugs Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Colorectal Cancer Drugs Market Share by Application in 2020 & 2026
Figure 6. Radiotherapy Examples
Figure 7. Chemotherapy Examples
Figure 8. Global Colorectal Cancer Drugs Sales (MT) Growth Rate (2015-2026)
Figure 9. Global Colorectal Cancer Drugs Revenue (US$ Million) Growth Rate (2015-2026)
Figure 10. Global Colorectal Cancer Drugs Price Trends Growth Rate (2015-2026) (USD/Kg)
Figure 11. Global Colorectal Cancer Drugs Revenue Market Share by Region: 2015 VS 2020
Figure 12. Global Colorectal Cancer Drugs Revenue Market Share by Region: 2021 VS 2026
Figure 13. United States Colorectal Cancer Drugs Revenue (Million USD) Growth Rate (2015-2026)
Figure 14. United States Colorectal Cancer Drugs Sales (MT) Growth Rate (2015-2026)
Figure 15. Europe Colorectal Cancer Drugs Revenue (Million USD) Growth Rate (2015-2026)
Figure 16. Europe Colorectal Cancer Drugs Sales (Million USD) Growth Rate (2015-2026)
Figure 17. China Colorectal Cancer Drugs Revenue (Million USD) Growth Rate (2015-2026)
Figure 18. China Colorectal Cancer Drugs Sales (Million USD) and Growth Rate (2015-2026)
Figure 19. Japan Colorectal Cancer Drugs Revenue (Million USD) Growth Rate (2015-2026)
Figure 20. Japan Colorectal Cancer Drugs Sales (Million USD) Growth Rate (2015-2026)
Figure 21. Southeast Asia Colorectal Cancer Drugs Revenue (Million USD) Growth Rate (2015-2026)
Figure 22. Southeast Asia Colorectal Cancer Drugs Sales (Million USD) Growth Rate (2015-2026)
Figure 23. India Colorectal Cancer Drugs Revenue (Million USD) Growth Rate (2015-2026)
Figure 24. India Colorectal Cancer Drugs Sales (Million USD) Growth Rate (2015-2026)
Figure 25. Global 5 Largest Colorectal Cancer Drugs Players Market Share by Revenue in Colorectal Cancer Drugs 2015 & 2019
Figure 26. Colorectal Cancer Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 27. Global Colorectal Cancer Drugs Revenue Share by Type (2015-2020)
Figure 28. Global Colorectal Cancer Drugs Revenue Growth Rate by Type in 2015 & 2019
Figure 29. Global Colorectal Cancer Drugs Revenue Share by Application (2015-2020)
Figure 30. Global Colorectal Cancer Drugs Revenue Growth Rate by Application in 2015 & 2019
Figure 31. United States Colorectal Cancer Drugs Sales Market Share by Type in 2019
Figure 32. United States Colorectal Cancer Drugs Sales Market Share by Type in 2019
Figure 33. Europe Colorectal Cancer Drugs Sales Market Share by Company in 2019
Figure 34. Europe Colorectal Cancer Drugs Sales Market Share by Type in 2019
Figure 35. Europe Colorectal Cancer Drugs Sales Market Share by Application in 2019
Figure 36. China Colorectal Cancer Drugs Sales Market Share by Company in 2019
Figure 37. China Colorectal Cancer Drugs Sales Market Share by Type in 2019
Figure 38. China Colorectal Cancer Drugs Sales Market Share by Application in 2019
Figure 39. Japan Colorectal Cancer Drugs Sales Market Share by Company in 2019
Figure 40. Japan Colorectal Cancer Drugs Sales Market Share by Type in 2019
Figure 41. Japan Colorectal Cancer Drugs Sales Market Share by Application in 2019
Figure 42. Southeast Asia Colorectal Cancer Drugs Sales Market Share by Company in 2019
Figure 43. Southeast Asia Colorectal Cancer Drugs Sales Market Share by Type in 2019
Figure 44. Southeast Asia Colorectal Cancer Drugs Sales Market Share by Application in 2019
Figure 45. India Colorectal Cancer Drugs Sales Market Share by Company in 2019
Figure 46. India Colorectal Cancer Drugs Sales Market Share by Type in 2019
Figure 47. India Colorectal Cancer Drugs Sales Market Share by Application in 2019
Figure 48. AB Science Total Revenue (US$ Million): 2019 Compared with 2018
Figure 49. Amgen Total Revenue (US$ Million): 2019 Compared with 2018
Figure 50. Array BioPharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 51. Bayer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 52. Boehringer Ingelheim Total Revenue (US$ Million): 2019 Compared with 2018
Figure 53. Bristol-Myers Squibb Total Revenue (US$ Million): 2019 Compared with 2018
Figure 54. Elli Lilly Total Revenue (US$ Million): 2019 Compared with 2018
Figure 55. Roch Total Revenue (US$ Million): 2019 Compared with 2018
Figure 56. Hutchison MediPharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 57. Merck & Co., Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 58. Mologen Total Revenue (US$ Million): 2019 Compared with 2018
Figure 59. Regeneron Total Revenue (US$ Million): 2019 Compared with 2018
Figure 60. Sanofi Total Revenue (US$ Million): 2019 Compared with 2018
Figure 61. Sumitomo Dainippon Total Revenue (US$ Million): 2019 Compared with 2018
Figure 62. Taiho Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 63. Vaccinogen Total Revenue (US$ Million): 2019 Compared with 2018
Figure 64. Key Raw Materials Price Trend
Figure 65. Manufacturing Cost Structure of Colorectal Cancer Drugs
Figure 66. Manufacturing Process Analysis of Colorectal Cancer Drugs
Figure 67. Colorectal Cancer Drugs Industrial Chain Analysis
Figure 68. Channels of Distribution
Figure 69. Distributors Profiles
Figure 70. Porter's Five Forces Analysis
Figure 71. Bottom-up and Top-down Approaches for This Report
Figure 72. Data Triangulation
Figure 73. Key Executives Interviewed
卵巣がん治療薬の世界市場レポート2020 Ovarian cancer is regarded as one of the most common types of cancer among women. It accounts for more deaths than any other cancer of the female reproductive system, while it ranks 5th in overall women deaths due to cancer. This type of cancer is rarely diagnosed at an early stage, making treatment…- 抗血管内皮増殖因子（抗VEGF）薬の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global marke…
- 大腸がん診断の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The Colorectal Cancer Diagnostics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optim…
- 乳がん治療薬の世界市場レポート2020 Breast Cancer Drugs are a type of drugs developed to cure or prevent breast cancer. Market Analysis and Insights: Global Breast Cancer Drugs Market Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization d…
- 転移性大腸がん治療の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Metastatic Colorectal Cancer Treatment market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Metast…